US FDA accepts Samsung Bioepis' application for Humira biosimilar September 27, 2018/0 Comments/in Hidradenitis suppurativa /by Steve… anti-tumor necrosis factor monoclonal antibody that currently treats Crohn's disease, rheumatoid arthritis, ulcerative colitis, hidradenitis suppurativa, … Source link Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on Google+ (Opens in new window) Related https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png 0 0 Steve https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png Steve2018-09-27 07:24:472018-09-27 07:24:47US FDA accepts Samsung Bioepis' application for Humira biosimilar
Leave a Reply
Want to join the discussion?Feel free to contribute!